Abstract: The coronavirus disease 2019 (COVID-19) pandemic has broad implications on stroke patient triage. Emergency medical services providers have to ensure timely transfer of patients while minimizing the risk of infectious exposure for themselves, their co-workers, and other patients. This statement paper provides a conceptual framework for acute stroke patient triage and transfer during the COVID-19 pandemic and similar healthcare emergencies in the future.
|Number of pages||5|
|State||Published - Jul 1 2020|
Bibliographical noteFunding Information:
Dr Goyal is a consultant for Medtronic, Stryker, Microvention, GE Healthcare, Mentice. Dr Ospel is supported by the Julia Bangerter Rhyner Foundation, University of Basel Research Foundation and Freiwillige Akademische Gesellschaft Basel. Dr Fraser is a consultant for Medtronic, Penumbra, Stream Biomedical, and reports ownership on Cerelux LLC, equity interest in Fawkes Biotechnology and grant supports by the University of Kentucky and the American Heart Association. Dr Southerland reported grants from Diffusion Pharmaceuticals, grants from AHA/ASA, grants from NSF, grants from Coulter Translational Research Foundation, and grants from HRSA outside the submitted work; in addition, Dr Southerland has a patent to (system, method and computer-readable medium for automated detection of neurological defects) pending and a patent to (Method, System, and Computer-Readable Medium for Improving Treatment Times for Rapid Evaluation of Acute Stroke via Mobile Telemedicine) pending; and Dr Southerland is past Editor of the Neurology Podcast, and provides legal expert consultation in cases involving stroke and cerebrovascular disease. The other authors report no conflicts.
© 2020 Lippincott Williams and Wilkins. All rights reserved.
ASJC Scopus subject areas
- Clinical Neurology
- Cardiology and Cardiovascular Medicine
- Advanced and Specialized Nursing